Globalization Act’s Drug Safety Provisions Look Harmful For Industry
This article was originally published in The Tan Sheet
Executive Summary
The FDA Globalization Act could be devastating to the drug industry while not creating the safety improvements that Congress expects, according to former FDA attorneys